Nanomedicine: Nanotechnology, Biology and Medicine
Volume 2, Issue 2 , Pages 66-73 , June 2006

A review of in vitro–in vivo investigations on dendrimers: the novel nanoscopic drug carriers

Received 24 December 2005 ,Accepted 7 April 2006.

References 

  1. Heller J. Use of polymers in controlled release of active agents. In:  Robinson JR,  Lee VHL editor. Controlled drug delivery fundamentals and applications. 2nd ed. New York: Marcel Dekker; 1987;p. 179–212
  2. Takenaga M. Application of lipid microsphere for treatment of cancer. Adv Drug Del Rev. 1996;20:209–219
  3. Duchene D, Ponchel G, Wouessidjewe D. Cyclodextrins in targeting: application to nanoparticle. Adv Drug Del Rev. 1999;36:29–40
  4. Lu Y, Chen SC. Micro and nano fabrication of biodegradable polymers for drug delivery. Adv Drug Del Rev. 2004;56:1621–1633
  5. Tomalia DA, Baker H, Dewald J, Hall M, Kallos G, Martin S, et al. A new class of polymers: starburst-dendritic macromolecules. Polym J. 1985;17:117–132
  6. Tomalia DA, Naylor AM, Goddard WA. Starburst dendrimers: molecular level control of size, shape, surface chemistry topology and flexibility from atoms to macroscopic matter. Angew Chem Int Ed Engl. 1990;29:138–175
  7. Baars MWPL, Kleppinger R, Koch MHJ, Yeu SL, Meijer EW. The localization of guests in water soluble oligoethyleneoxy modified poly(propylene imine) dendrimers. Angew Chem Int Ed. 2000;39:1285–1288
  8. Stevelmens S, Hest JCM, Jansen JFGA, Boxtel DAFJ, de Bravander-van den B, Miejer EW. Synthesis, characterization and guest-host properties of inverted unimolecular micelles. J Am Chem Soc. 1996;118:7398–7399
  9. El-Sayed M, Rhodes CA, Ginski M, Ghandehari H. Transport mechanism (s) of poly (amidoamine) dendrimers across Caco-2 cell monolayers. Int J Pharm. 2003;265:151–157
  10. Tajarobi F, El-Sayed M, Rege BD, Polli JE, Ghandehari H. Transport of polyamido amine dendrimers across Madin-Darby canine kidney cells. Int J Pharm. 2001;215:263–267
  11. Jevprasesphant R, Penny J, Attwood D, D'Emanuele A. Transport of dendrimer through epithelial cells via the transcellular route. J Control Release. 2004;97:259–267
  12. Haensler J, Szoka FC. Polyamidoamine cacade polymers mediate efficient transfection of cells in culture. Bioconjug Chem. 1993;4:372–379
  13. Tang MX, Redemann CT, Szoka FC. In vitro gene delivery by degraded polyamidoamine dendrimers. Bioconjug Chem. 1996;7:703–714
  14. Schatzlein AG, Zinselmeyer BH, Elouzi A, Dufes C, Chim YTA, Roberts CJ, et al. Preferential liver gene expression with polypropylene imine dendrimers. J Control Release. 2005;101:247–258
  15. Bielinska A, Kukowska-Latallo JF, Johnson J, Tomalia DA, Baker J. Regulation of in vitro gene expression using antisense oligonucleotide or antisense expression plasmids transfected using starburst PAMAM dendrimers. Nucleic Acids Res. 1996;24:2176–2182
  16. Kukowska-Latallo JF, Bielinska AU, Johnson J, Spindler R, Tomalia DA, Baker J. Efficient transfer of genetic material into mammalian cells using starburst polyamidoamine dendrimers. Proc Natl Acad Sci U S A. 1996;93:4897–4902
  17. Kihara F, Arima H, Tsutsumi T, Hirayama F, Uekama K. In vitro and in vivo gene transfer by optimised α-cyclodextrin conjugate with polyamido amine dendrimer. Bioconjug Chem. 2003;14:342–350
  18. Lim YB, Kim T, Lee JW, Kim SM, Kim HJ, Kim K, et al. Self-assembley ternary complex of cationic dendrimer, Cucurbituril and DNA. Non-covalent strategy in developing a gene delivery. Bioconjug Chem. 2002;13:1181–1185
  19. Wiener EC, Brechbiel MW, Brothers H, Magin RL, Gansow OA, Tomalia DA, et al. Dendrimer-based metal chelates: a new class of magnetic resonance imaging contrast agents. Magn Reson Med. 1994;31:1–8
  20. Konda SD, Aref M, Wang S, Brechbiel M, Wiener EC. Specific targeting of folate-dendrimer MRI contrast agents to the high affinity folate receptor expressed in ovarian tumor xenografts. Magn Reson Mater Phys Biol Med. 2001;12:104–113
  21. Wu C, Brechbiel MW, Kozak RW, Gansow OA. Metal-chelate-dendrimer-antibody-constructs for use in radioimmunotherapy and imaging. Bioorg Med Chem Lett. 1994;4:449–454
  22. Milhem OM, Myles C, McKeown NB, Attwood D, D'Emanuele A. Polyamidoamine Starburst dendrimers as solubility enhancers. Int J Pharm. 2000;197:239–241
  23. Hawker CJ, Wooley KL, Frechet JMJ. Unimolecular micelles and globular amphiphiles: dendritic macromolecules as novel recyclable solubilization agents. J Chem Soc Perkin Trans. 1993;1:1287–1297
  24. Devarakonda B, Hill RA, De Villiers MM. The effect of PAMAM dendrimer generation size and surface functional groups on the aqueous solubility of nifedipine. Int J Pharm. 2004;284:133–140
  25. Asthana A, Chauhan AS, Diwan PV, Jain NK. Poly(amidoamine) (PAMAM) dendritic nanostructures for controlled site-specific delivery of acidic anti-inflammatory active ingredient. AAPS Pharm Sci Tech. 2005;27:536–542
  26. Ooya T, Lee J, Park K. Effects of ethylene glycol–based grafts, star-shaped, and dendritic polymers on solubilization and controlled release of paclitaxel. J Control Release. 2003;93:121–127
  27. Devarakonda B, Hill RA, Liebenberg W, Brits M, De Villiers MM. Comparision of the aqueous solubilization of practically insoluble niclosamide by polyamidoamine (PAMAM) dendrimers and cyclodextrins. Int J Pharm. 2005;300:193–209
  28. Bhadra D, Bhadra S, Jain NK. Pegylated lysine based copolymeric dendritic micelles for solubilization and drug delivery of artemether. J Pharm Pharm Sci. 2005;8:467–482
  29. Neofotistou E, Demadis KD. Use of antiscalants for mitigation of silica (SiO2) fouling and deposition: fundamentals and application in desalination system. Desalination. 2004;167:257–272
  30. Aulenta F, Hayes W, Rannard S. Dendrimers: a new class of nanoscopic containers and delivery devices. Eur Polym J. 2003;39:1741–1771
  31. Bosman AW, Janssen HM, Meijer EW. About dendrimers: structure, physical properties and applications. Chem Rev. 1999;99:1665–1688
  32. Esfand R, Tomalia DA. Poly(amidoamine) (PAMAM) dendrimers: from biomimicry to drug delivery and biomedical applications. Drug Discov Today. 2001;6:427–436
  33. Patri AK, Majoros IJ, Baker JR. Dendritic polymer macromolecular carriers for drug delivery. Curr Opin Chem Biol. 2002;6:466–471
  34. Cloninger MJ. Biological applications of dendrimers. Curr Opin Chem Biol. 2002;6:742–748
  35. Gillies ER, Frechet JMJ. Dendimers and dendritic polymer in drug delivery. Drug Discov Today. 2005;10:35–43
  36. Patri AK, Kukowska-Latallo JF, Baker JR. Transdermal drug delivery with dendrimers: comparison of the release kinetics of the covalently conjugated drug and non covalent drug inclusion complex. Adv Drug Del Rev. 2005;57:2203–2214
  37. Bhadra D, Bhadra S, Jain S, Jain NK. A PEGylated dendritic nanoparticulate carrier of fluorouracil. Int J Pharm. 2003;257:111–124
  38. Bhadra D, Bhadra S, Jain NK. PEGylated peptide based dendritic nanoparticulate systems for delivery of artemether. J Drug Del Sci Tech. 2005;15:65–73
  39. Bhadra D, Yadav AK, Bhadra S, Jain NK. Glycodendrimeric nanoparticulate carriers of primaquine phosphate for liver targeting. Int J Pharm. 2005;295:221–233
  40. Padilla De Jesus OL, Ihre HR, Gague L, Frechet JMJ, Szoka FC. Polyester dendritic systems for drug delivery applications in vitro and in vivo evaluation. Bioconjug Chem. 2002;13:453–461
  41. Ihre HR, Padilla De Jesus OL, Szoka FC, Frechet JMJ. Polyester dendrimer systems for drug delivery applications design, synthesis and characterization. Bioconjug Chem. 2002;13:443–452
  42. Neerman MF, Zhang W, Parrish AR, Simanek EE. In vivo and in vitro evaluation of a melamine dendrimer as a vehicle for drug delivery. Int J Pharm. 2004;281:129–132
  43. Zhang W, Jiang J, Qin C, Thomson LM, Parrish AR, Safe SH, et al. Triazine dendrimers for drug delivery: evaluations of solubilization properties activity in cell culture and in vivo toxicity of a candidate vehicle. Supramol Chem. 2003;15:607–615
  44. Chen HT, Neerman MF, Parrish AR, Simanek EE. Cytotoxicity haemolysis and acute in vivo toxicity of dendrimers based on melamine, candidate vehicles for drug delivery. J Am Chem Soc. 2004;126:10044–10048
  45. Wang Z, Itoh Y, Hosaka Y, Kobayashi I, Nakamo Y, Maeda I, et al. Novel transdermal drug delivery system with polyhydroxyalkanoate and starburst polyamido amine dendrimers. J Biosci Bioeng. 2003;95:541–543
  46. Wang Z, Iton Y, Hosaka Y, Kobayashi I, Nakano Y, Maeda I, et al. Mechanism of enhancement effect of dendrimer on transdermal drug permeation through poly hydroxy alkanoate matrix. J Biosci Bioeng. 2003;96:537–540
  47. Chauhan AS, Sridevi S, Chalasani KB, Jain AK, Jain SK, Jain NK, et al. Dendrimer-mediated transdermal delivery: enhanced bioavailability of indomethacin. J Control Release. 2003;90:335–343
  48. Vandamme TF, Brobeck L. Polyaminido amine dendrimers as ophthalmic vehicles for ocular delivery of pilocarpine nitrate and tropicamide. J Control Release. 2005;102:23–38
  49. Wiwattanapatapee R, Correno-Gomez B, Malik N, Duncan R. Anionic PAMAM dendrimers rapidly cross adult rat intestine in vitro: a potential oral delivery system. Pharm Res. 2000;17:991–998
  50. Florence AT, Sakthivel T, Toth I. Oral uptake and translocation of poly lysine dendrimer with a lipid surface. J Control Release. 2000;65:253–259
  51. Tripathi PR, Khopade AJ, Nagaich S, Shrivastava S, Jain S, Jain NK. Dendrimer grafts for delivery of 5-fluorouracil. Pharmazie. 2002;57:261–264
  52. D'Emanuele A, Jevprasesphant JP, Penny J, Attwood D. The use of a dendrimer propranolol prodrug to bypass efflux transporters and enhance oral bioavailability. J Control Release. 2004;95:447–453
  53. Yang L, Chu JS, Fix JA. Colon specific drug delivery: new approaches and in vitro/in vivo evaluation. Int J Pharm. 2002;235:1–15
  54. Kopecek J, Kopeckova P, Brondsted H, Rathi R, Rihova B, Yeh PY, et al. Polymers for colon specific drug delivery. J Control Release. 1992;19:121–130
  55. Sinha VR, Kumaria R. Colonic drug delivery: prodrug approach. Pharm Res. 2001;18:557–564
  56. Wiwattanapatapee R, Lomlim L, Saramunce K. Dendrimers conjugates for colonic delivery of 5-amino salicylic acid. J Control Release. 2003;88:1–9
  57. Quintana A, Raczka E, Piehler L, Lee I, Myc A, Majoros I, et al. Design and function of a dendrimer based therapeutic nanodevice targeted to tumor cells through the folate receptor. Pharm Res. 2002;19:1310–1316
  58. Yang M, Lopina ST. Penicillin V-conjugated PEG-PAMAM star polymers. J Biomater Sci Polym Ed. 2003;14:1043–1056
  59. Sideratou Z, Tsiourvas D, Paleos CM. Solubilization and release properties of PEGylated diaminobutane polypropyleneimine dendrimers. J Colloid Interface Sci. 2001;242:272–276
  60. Kojima C, Kono K, Maruyama K, Takagishi T. Synthesis of polyamidoamine dendrimers having poly(ethylene glycol) grafts and their ability to encapsulate anticancer drugs. Bioconjug Chem. 2000;11:910–917

 No financial conflict of interest was reported by the authors of this paper.

PII: S1549-9634(06)00042-6

doi: 10.1016/j.nano.2006.04.002

Nanomedicine: Nanotechnology, Biology and Medicine
Volume 2, Issue 2 , Pages 66-73 , June 2006

Article Tools

* Image Usage & Resolution